Clinical Practice Guidelines Based on Evidence for Cognitive-Behavioral Therapy in Parkinson's Disease Comorbidities: A Literature Review.

  title={Clinical Practice Guidelines Based on Evidence for Cognitive-Behavioral Therapy in Parkinson's Disease Comorbidities: A Literature Review.},
  author={Iva Ze{\vc}evi{\'c}},
  journal={Clinical psychology \& psychotherapy},
  • I. Zečević
  • Published 20 March 2020
  • Psychology, Medicine
  • Clinical psychology & psychotherapy
Purpose of this review is to provide psychologists and other health care professional enough knowledge about available cognitive-behavioral interventions for comorbidities in Parkinson's disease that include depression, anxiety, impulsive disorder, pain and sleep disturbances. This review has clear clinical practical suggestions how to adapt psychological interventions and techniques to the motor and/or cognitive impairments of patients with Parkinson's disease, based on earlier available… 
Psychological interventions for people with Parkinson's disease in the early 2020s: Where do we stand?
CBT appears to be effective in treating depression and sleep disorders in people with PD, while psychoeducation programmes alone should be avoided, and caution is advised regarding the use of CBT and mindfulness-based interventions to improve anxiety, quality of life, and impulse control.
Cognitive and Physical Intervention in Metals’ Dysfunction and Neurodegeneration
Physical and cognitive rehabilitation methods of patients associated with metal-induced neurotoxicity such as Alzheimer’s disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease and Wilson's disease are described, significantly improving the quality of life and independence of patientsassociated with storage diseases.


Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review.
Results of individual studies varied significantly; however, the randomized controlled trials showed encouraging results and support the need for further investigation of the utility of CBT for depressed and anxious patients with PD.
Palliative Care in Parkinson's Disease: Role of Cognitive Behavior Therapy
  • S. Mallick
  • Psychology, Medicine
    Indian journal of palliative care
  • 2009
CBT has a strong evidence base for its use and has proven to be an effective treatment in management of people with chronic pain, fatigue syndrome, depression and sleep disturbances, with efficacy that lasts beyond the duration of treatment.
Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial.
CBT may be a viable approach for the treatment of depression in Parkinson's disease and further research is needed to replicate and extend these findings.
Cognitive behavioural treatment for mild Alzheimer’s patients and their caregivers (CBTAC): study protocol for a randomized controlled trial
This randomized controlled trial aims to evaluate a CBT-based treatment programme consisting of 8 modules and 25 sessions that has the potential to establish an empirically based psychological treatment for non-cognitive symptoms that reduce the quality of life of a person with dementia and a caregiver.
The Role of Cognitive-Behavioural Therapy for Patients with Depression in Parkinson's Disease
Cognitive behavioural therapy (CBT) is shown to be an effective treatment of depressive disorders and a number of case reports, case series, and small pilot studies suggest that this is a promising treatment for patients with PD.
Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease
Evidence is reviewed demonstrating that cognitive behavior therapy (CBT) is effective in the treatment of depression and anxiety in Parkinson’s disease and it is argued that treatment should take into account specific cognitive and behavioral maintaining factors.
Cognitive-Behavioral Therapy for Anxiety in Parkinson’s Disease
Preliminary evidence for the utility and feasibility of CBT as a feasible treatment for anxiety and comorbid depressive symptoms in PD is provided and the potential of telehealth interventions for mood in this population is highlighted.
Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's disease.
Caregiver participation may enhance acute treatment response to psychosocial interventions for depression in PD, and both caregiver participation and executive functioning predicted response to CBT.
Efficacy of cognitive behavioral therapy for insomnia comorbid to Parkinson's disease: A focus on psychological and daytime functioning with a single-case design with multiple baselines.
CBT-i was associated with significant changes in sleep variables and ID criteria, and significant positive treatment-related effects were also noted for all indices of daytime and psychological functioning, and for variables perpetuating ID.